sergeitokmakov/Pixabay

Penny stocks are stocks that typically trade at $5 or less. These stocks are mostly small companies that typically trade over-the-counter (OTC).

Some penny stocks, however, trade on primary exchanges. These stocks are a popular way to get quick and big returns, but it’s not without risk as these stocks are extremely volatile.

Liquidity is also a concern for these stocks. To give you an idea of ​​how much money you could make or lose with penny stocks, below are the five best and worst performing penny stocks of 2022.

The Hedge Funds’ Struggle for Stock Selection in Volatile Markets

This year has been a tough year for stock pickers. The S&P 500 stock index is down 16% so far this year, putting it on track for its worst year since 2008. While those numbers might not look so bad at first glance, the dispersion yields between the best and the worst performers Read More

Get the full Ray Dalio series in PDF

Get the entire 10-part series on Ray Dalio in PDF. Save it to your desktop, read it on your tablet, or email it to co-workers

Q2 2022 Hedge Fund Letters, Talks & More

Five Best Performing Penny Stocks of 2022

We used year-to-date (as of September 1, 2022) stock price and performance data from stocks trading below $5 to rank the five best and worst performing penny stocks of 2022.

  1. Mammoth Energy Services (126%)

Founded in 2016 and based in Oklahoma City, this company explores and develops North American onshore reserves of unconventional oil and natural gas.

Mammoth Energy Services Inc (NASDAQ:TUSK) shares are up more than 13% in the past year and nearly 87% in the past three months.

As of this writing, shares of Mammoth Energy Services are trading over $4 (52-week range of $1.3500 to $5.2949), giving it a market capitalization of over $190 million. of dollars.

  1. Alaunos Therapeutic (176%)

Founded in 2003 and based in Houston, it is a cell therapy company focused on biopharmaceutical and clinical oncology.

Shares of Alaunos Therapeutics Inc (NASDAQ:TCRT) are up more than 70% in the past year and more than 500% in the past three months.

As of this writing, shares of Alaunos Therapeutics are trading at over $2.90 (52-week range of $0.4053 to $3.0600), giving it a market capitalization of over $530 million.

  1. Houston American Energy (185%)

Founded in 2001 and based in Houston, this company develops, explores, acquires and produces natural gas and crude oil properties.

Shares of Houston American Energy Corporation (NYSEAMERICAN:HUSA) have risen more than 113% in the past year, but are down more than 8% in the past three months.

As of this writing, shares of Houston American Energy are trading above $4.10 (52-week range of $1.07 to $16.61), giving it a market capitalization of more than $40 million.

  1. New Energy Service (205%)

Founded in 2011 and based in Houston, this company offers oilfield services, including onshore completion and production services.

Shares of Nine Energy Service Inc (NYSE:NINE) are up more than 38% in the past year, but down more than 9% in the past three months.

As of this writing, shares of Nine Energy Service are trading at over $3.30 (52-week range of $0.7940 to $8.1000), giving it a market capitalization of over $110 million.

  1. Trevi Therapeutic (301%)

Founded in 2011 and based in New Haven, Connecticut, it is a clinical-stage biopharmaceutical company that develops and markets Haduvio to treat serious neurologically mediated conditions.

Shares of Trevi Therapeutics Inc (NASDAQ:TRVI) are up nearly 86% in the past year and more than 25% in the past three months.

As of this writing, shares of Trevi Therapeutics are trading at over $3.20 (52-week range of $0.4600 to $4.6834), giving it a market capitalization of over $130. millions of dollars.

Five Worst Performing Penny Stocks of 2022

  1. Organic Baudax (-96%)

Founded in 2015 and based in Malvern, Pennsylvania, this company develops and sells products for acute care settings.

Shares of Baudax Bio Inc (NASDAQ:BXRX) are down nearly 99% in the past year and more than 56% in the past three months.

At the time of this writing, shares of Baudax Bio are trading at over $0.33 (52-week range of $0.3075 to $25.3050), giving it a market capitalization of over 2 .70 million.

  1. Biosciences Revelation (-96%)

Founded in 2019 and based in San Diego, this company develops immunological therapies for the prevention and treatment of diseases.

Shares of Revelation Biosciences Inc (NASDAQ:REVB) are down more than 96% in the past year and more than 19% in the past three months.

At the time of this writing, shares of Revelation Biosciences are trading at over $0.39 (52-week range of $0.3801 to $11.2900), giving it a market capitalization of over $5. millions of dollars.

  1. Quanergy systems (-97%)

Founded in 2012 and based in Sunnyvale, Calif., this company develops intelligent LiDAR sensor security hardware and software solutions for automotive and IoT use.

Shares of Quanergy Systems Inc (NYSE:QNGY) are down more than 97% in the past year and nearly 48% in the past three months.

As of this writing, Quanergy Systems shares are trading at over $0.284 (52-week range of $0.27 to $10.10), giving it a market capitalization of over $35 million. dollars.

  1. Clarus therapeutic participations (-98%)

Founded in 2004 and based in Northbrook, Illinois, this pharmaceutical company develops androgen and metabolic therapies for men and women.

Shares of Clarus Therapeutics Holdings Inc (OTCMKTS:CRXT) are down more than 99% in the past year and nearly 90% in the past three months.

As of this writing, shares of Clarus Therapeutics Holdings are trading at $0.05 (52-week range of $0.05 to $10.57), giving it a market cap of over 3, $5 million.

  1. Agile Therapeutics (-98%)

Founded in 1997 and based in Princeton, NJ, it is a healthcare company that develops and markets transdermal patches.

Shares of Agile Therapeutics Inc (NASDAQ:AGRX) are down more than 99% in the past year and nearly 72% in the past three months.

As of this writing, Agile Therapeutics shares are trading at over $0.38 (52-week range of $0.37 to $50.40), giving it a market capitalization of over $15 million. of dollars.